Safety Qualms, Slow Demand Hamper J&J Vaccine Rollout in U.S. June 7, 2021 By Michael Erman Safety concerns about Johnson & Johnson’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout...
WHO Says China’s Vaccine Prevents COVID But Questions Data on Side Effects: Reuters May 6, 2021 By Stephanie Nebehay WHO experts have voiced “very low confidence” in data provided by Chinese state-owned drugmaker Sinopharm on its COVID-19 vaccine regarding...
J&J to Resume Shipments of COVID-19 Vaccine to EU with Safety Warning April 21, 2021 By Manas Mishra and Carl O'Donnell Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region’s medical...
Task of Tracking COVID-19 Vaccine Safety Falls to Multiple Federal Agencies November 18, 2020 By Anna Edney Monitoring Covid-19 vaccines for safety issues will fall to a group of U.S. health agencies that also will have a...
9 Coronavirus Vaccine Developers Pledge to Uphold Scientific Safety Standards September 7, 2020 By Ludwig Burger and Patricia Weiss Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards that their experimental immunisations will...
U.S. Drug Regulator Vows Outside Review of Any COVID-19 Vaccines August 11, 2020 The United States will need to have independent experts review COVID-19 vaccine candidates before approval, the country’s top drug regulator...
Vaccine Claims System Slow to Compensate Injured November 26, 2014 By Mitch Weiss, Justin Pritchard and Troy Thibodeaux All but broken by her son’s violent and unexplained seizures, by so many panicked trips from the crib to the...